Siegrist CA - Search Results

1

Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children.

Meier S, Bel M, L'huillier A, Crisinel PA, Combescure C, Kaiser L, Grillet S, Pósfay-Barbe K, Siegrist CA; H1N1 Epidemiology Study Group of Geneva. Meier S, et al. Among authors: siegrist ca. Vaccine. 2011 Apr 27;29(19):3548-57. doi: 10.1016/j.vaccine.2011.02.094. Epub 2011 Mar 17. Vaccine. 2011. PMID: 21419775

2

Potential advantages and risks of nucleic acid vaccines for infant immunization.

Siegrist CA. Siegrist CA. Vaccine. 1997 Jun;15(8):798-800. doi: 10.1016/s0264-410x(96)00253-8. Vaccine. 1997. PMID: 9234517 Review.

3

Determinants of infant responses to vaccines in presence of maternal antibodies.

Siegrist CA, Córdova M, Brandt C, Barrios C, Berney M, Tougne C, Kovarik J, Lambert PH. Siegrist CA, et al. Vaccine. 1998 Aug-Sep;16(14-15):1409-14. doi: 10.1016/s0264-410x(98)00100-5. Vaccine. 1998. PMID: 9711780

4

Induction of neonatal TH1 and CTL responses by live viral vaccines: a role for replication patterns within antigen presenting cells?

Siegrist CA, Saddallah F, Tougne C, Martinez X, Kovarik J, Lambert PH. Siegrist CA, et al. Vaccine. 1998 Aug-Sep;16(14-15):1473-8. doi: 10.1016/s0264-410x(98)00111-x. Vaccine. 1998. PMID: 9711791

5

Neonatal and early life vaccinology.

Siegrist CA. Siegrist CA. Vaccine. 2001 May 14;19(25-26):3331-46. doi: 10.1016/s0264-410x(01)00028-7. Vaccine. 2001. PMID: 11348697 Review.

6

Response to treatment and disease progression linked to CD4+ T cell surface CC chemokine receptor 5 density in human immunodeficiency virus type 1 vertical infection.

Gervaix A, Nicolas J, Portales P, Posfay-Barbe K, Wyler CA, Segondy M, Avinens O, Siegrist CA, Clot J, Eliaou JF, Astruc J, Corbeau P. Gervaix A, et al. Among authors: siegrist ca. J Infect Dis. 2002 Apr 15;185(8):1055-61. doi: 10.1086/339802. Epub 2002 Apr 1. J Infect Dis. 2002. PMID: 11930315

7

CpG-motifs enhance initial and sustained primary tetanus-specific antibody secreting cell responses in spleen and bone marrow, but are more effective in adult than in neonatal mice.

Pihlgren M, Tougne C, Schallert N, Bozzotti P, Lambert PH, Siegrist CA. Pihlgren M, et al. Among authors: siegrist ca. Vaccine. 2003 Jun 2;21(19-20):2492-9. doi: 10.1016/s0264-410x(03)00052-5. Vaccine. 2003. PMID: 12744883

8

Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants.

Siegrist CA. Siegrist CA. Vaccine. 2003 Jul 28;21(24):3406-12. doi: 10.1016/s0264-410x(03)00342-6. Vaccine. 2003. PMID: 12850349 Review.

9

Influence of complement C3 amount on IgG responses in early life: immunization with C3b-conjugated antigen increases murine neonatal antibody responses.

Pihlgren M, Fulurija A, Villiers MB, Tougne C, Lambert PH, Villiers CL, Siegrist CA. Pihlgren M, et al. Among authors: siegrist ca. Vaccine. 2004 Dec 2;23(3):329-35. doi: 10.1016/j.vaccine.2004.06.010. Vaccine. 2004. PMID: 15530677

10

Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response.

Siegrist CA, Pihlgren M, Tougne C, Efler SM, Morris ML, AlAdhami MJ, Cameron DW, Cooper CL, Heathcote J, Davis HL, Lambert PH. Siegrist CA, et al. Vaccine. 2004 Dec 16;23(5):615-22. doi: 10.1016/j.vaccine.2004.07.014. Vaccine. 2004. PMID: 15542181 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

308 results

Search Page

Filters